Funding & Support

Healthcare organizations and professionals can apply for a medical education grant to support bonafide educational programs and activities related to disease awareness and improvement of patient care. To be eligible, applicants must meet the following requirements:

• Demonstrate that the proposed medical education provided through the grant will promote improved delivery of healthcare.
• Be an independent, accredited medical educator that conforms to FDA and ACCME standards.
• The proposed medical education is not satisfied under existing programs.
• Must complete an agreement with Crinetics.

Crinetics invites accredited educational providers to submit applications for independent, certified medical education grants subject to the terms described below. This Request for Proposals (RFP) provides public notice of the availability of funds in a general topic area for activities for which recognized scientific or educational needs exist and funding is available.

There are no RFPs at this time. Please continue to check here for available RFPs. 

Apply

For any questions, please contact [email protected].

Independent endocrine disease research may also qualify for funding. You may qualify if you meet the following requirements:

• Research demonstrates familiarity with Crinetics’ investigational treatments:
  • Paltusotine, an oral nonpeptide selective SST2 agonist for the treatment of Acromegaly and Carcinoid syndrome associated with neuroendocrine tumors.
  • CRN04894, an ACTH (MC2R) antagonist for the treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH Dependent Cushing’s Syndrome (ADCS).
• Crinetics is happy to consider investigator-initiated research proposals relevant to these disease states, in the following areas:
  • Epidemiology (including real-world evidence and burden of disease research).
  • Stability of disease control achieved by current treatments and associated impact on patients, healthcare providers, and healthcare systems.
  • Evaluation of patient-reported outcome tools.
  • Research related to other diseases that may be appropriate for treatment with an ACTH antagonist can be considered on a case-by-case basis.
• Deliverables are tangible and follow scientific methods.
• Crinetics’ support of the research must be clearly acknowledged and disclosed in all publication of study data and results.
• The IIS applicant is solely responsible and exercises full control of the execution and planning of the study.
• Must complete an agreement with Crinetics.

Apply

For any questions, please contact [email protected].

• Letter of request, signed and dated on your organization’s letterhead, that includes the following:
  • Educational objectives
  • Needs assessment
  • Agenda
  • Full program budget
  • Program description that includes how you will use the grant
  • Anticipated number of participants
  • Name of accrediting body and provider, including type and amount of credits (must be accredited)
• W-9 form (US) or W-8 (non-US)
• IRS tax determination letter (if applicable)
• Before the start of a medical education grant, an agreement must be complete and fully executed.

• Letter of request, signed and dated on your organization’s letterhead, that includes the following:
  • Scientific rationale
  • Scope and objective of the study
  • Methodology, including patient selection criteria, study design, sample size justification, dosing (if applicable), and a data analysis plan
  • Data reporting plan
  • Nature and amount of support requested
  • Projected timeline
  • Curriculum Vitae for all investigators
• W-9 form (US) or W-8 (non-US)
• IRS tax determination letter (if applicable)
• If funded, a final study report (publication can be in lieu of study report) must be provided upon completion of study, and Crinetics’ support must be acknowledged in all publications/presentations of study data
• Funding will not be provided for:
  • Individuals
  • Fellowships
  • Overhead and general operating expenses
  • Entertainment, including meals
  • Awards
  • Travel
• Before the start of an IIS, an agreement must be complete and fully executed.